US biotech major Regeneron Pharmaceuticals has announced a significant expansion of its manufacturing capacity through a new ...

San Diego-based iBio, an AI-driven innovator of precision antibody therapies, has announced a licensing agreement with ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance ...

A clinical-stage biotech company developing bifunctional small-molecule therapeutics designed to eliminate disease-driving ...

US clinical-stage biotech Halda Therapeutics today announced that Dr Eyal Attar has joined the company as chief medical ...

A clinical-stage biotech company developing first-in-class targeted and immune-mediated therapeutics to fight cancer.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi (marstacimab) to prevent or reduce bleeding in patients 12 years of age and older weighing at least 35kg with ...

Harvard University has filed a lawsuit against the US government after more than $2 billion in federal research funding was ...

A biotech company integrating of AI and synthetic biology to design safer and more effective antibody therapeutics.

Adding to the list of pharma majors starting or expanding production in the USA, Swiss pharma giant Roche (ROG: SIX) today announced that it will invest $50 billion into America in the next five years ...

Japan’s Ono Pharmaceutical and privately-held US firm Jorna Therapeutics are ready to go in a research collaboration ...

South Korea-based biotech firms 1ST Biotherapeutics and LigaChem Biosciences (Kosdaq: 141080) have entered a strategic ...